이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Zhende Medical 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jianguo Lu

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	8yrs
CEO 소유권	1.5%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	2yrs

최근 관리 업데이트

Recent updates

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Apr 29

CEO

Jianguo Lu (54 yo)

8yrs

테뉴어

CN¥1,600,000

보상

Mr. Jianguo Lu is Chairman of the Board and General Manager of Zhende Medical Co., Ltd. from July 07, 2016.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Jianguo Lu	Chairman of the Board & GM	8yrs	CN¥1.60m	1.47% CN¥ 84.5m
Zhendong Shen	Director & Deputy GM	no data	CN¥932.40k	0.22% CN¥ 12.8m
Dasheng Xu	Deputy GM & Director	no data	CN¥1.49m	0.098% CN¥ 5.6m
Jia Feng Wang	Director	no data	CN¥121.60k	0.00019% CN¥ 10.9k
Sheng Xiao Li	Independent Director	2yrs	CN¥64.90k	데이터 없음
Xiantao Zhang	Director	no data	CN¥635.00k	0.033% CN¥ 1.9m
Xiuyuan Hu	Chairman of the Supervisory Board	no data	데이터 없음	0.044% CN¥ 2.5m
Chafen Zhu	Independent Director	2yrs	데이터 없음	데이터 없음

2.0yrs

평균 재임 기간

50yo

평균 연령

경험이 풍부한 이사회: 603301 의 이사회는 경험(평균 재직 기간 1.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

Zhende Medical 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Less than half of directors are independent

No independent directors

Recent updates

Zhende Medical Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Does Zhende Medical (SHSE:603301) Have A Healthy Balance Sheet?

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

Zhende Medical Co., Ltd., Annual General Meeting, May 20, 2024

New major risk - Financial data availability

Zhende Medical Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued after recent price drop

New major risk - Revenue and earnings growth

Zhende Medical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial data availability

New major risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.71 in 2Q 2022)

Zhende Medical Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

First quarter 2023 earnings released: EPS: CN¥0.55 (vs CN¥0.50 in 1Q 2022)

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.81 (vs CN¥0.46 in 3Q 2021)

Investor sentiment improved over the past week

Zhende Medical Co., Ltd. announced that it has received CNY 976.452074 million in funding from Zhejiang Zhende Holding Co., Ltd., Xuchang Zhende Landscaping Engineering Co., Ltd.

Second quarter 2022 earnings released: EPS: CN¥0.71 (vs CN¥0.54 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

No independent directors

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.46 (vs CN¥5.57 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.54 (vs CN¥4.63 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥1.12 (vs CN¥0.44 in 1Q 2020)

New 90-day low: CN¥56.86

New 90-day low: CN¥59.35

Third quarter earnings released

Zhende Medical Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020

Earnings released

New 90-day high - CN¥99.22

Zhende Medical Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령